Moderna’s Fully Enrolled Phase 3 COVE Study of mRNA-1273

Eligible participants must be: (There are additional eligibility requirements, which the study physician can explain.) 18+ Adults who are 18 years of age and older New to Studies Free from prior exposure to an investigational vaccine or treatment for COVID-19; High Risk At high risk of COVID-19 infection (defined as adults whose locations or circumstances put them at greater risk of exposure …

https://www.modernatx.com/cove-study